# A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

> **NCT01770418** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Proton Collaborative Group** · enrollment: 32 (actual)

## Conditions studied

- Lung Neoplasms

## Interventions

- **RADIATION:** Radiation with Concurrent Chemotherapy

## Key facts

- **NCT ID:** NCT01770418
- **Lead sponsor:** Proton Collaborative Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-03
- **Primary completion:** 2038-01
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01770418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01770418, "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01770418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*